←back to thread

Antiviral chewing gum to reduce influenza and herpes simplex virus transmission

(penntoday.upenn.edu)
180 points gnabgib | 1 comments | 09 Apr 25 19:09 UTC | HN request time: 0.26s | source
Show context
sitkack ◴[09 Apr 25 19:49 UTC] No.43636938[source]▶
PSA, everyone should be getting the HPV vaccine, regardless of age and gender.

https://en.wikipedia.org/wiki/HPV_vaccine

https://www.mdanderson.org/publications/focused-on-health/wh...

https://www.cdc.gov/cancer/hpv/oropharyngeal-cancer.html

replies(10): >>43637174 #>>43637565 #>>43637753 #>>43637969 #>>43638326 #>>43638655 #>>43638679 #>>43638750 #>>43638758 #>>43638803 #
0cf8612b2e1e ◴[09 Apr 25 20:30 UTC] No.43637565[source]▶
Annoyed at how the guidance has changed on this over the years. At first it was just a narrow slice of 20 something women. Then girl teenagers. Then men and women under 30. Then under 40.

If it has an association with preventing cancers, not sure why they were so reluctant to immediately open up the patient pool.

replies(9): >>43637725 #>>43637966 #>>43638209 #>>43638268 #>>43638858 #>>43639128 #>>43639177 #>>43639857 #>>43640671 #
1. stubish ◴[10 Apr 25 01:48 UTC] No.43639857[source]▶
You can only sell medication after trials. The first trials were on young women, and later trials on other groups. Nobody wanted to pay for trials on all demographics before there was evidence it worked from cheaper, more focused trial. There are also barriers to doing trials on high risk groups like the elderly without first testing on lower risk demographics.

This is one reason why so much medication not to be used by pregnant women. The trials have not been done, and trials involving pregnant women are particularly expensive and risky.